Santen Pharmaceutical Co., Ltd. announced that payment for the disposal of treasury shares as post-delivery performance-linked stock compensation had been completed. The announcement was made at 16:00 on 30 September 2026, based on announcement materials from Nikkei Company Information DIGITAL.
Santen Pharmaceutical Co., Ltd. announced the completion of payment in connection with the disposal of treasury shares for post-delivery performance-linked stock compensation. The transaction was carried out as part of the company's compensation program.
The announcement was made at 16:00 on 30 September 2026, and detailed information was published in announcement materials from Nikkei Company Information DIGITAL.